← Leaderboards
Sarah M. Belcher
University Of Pittsburgh At Pittsburgh
$1,651,315
Attributed
$1,651,315
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $656.6K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,651,315 · 2
By mechanism
R01$1,283,191 · 1
K23$368,124 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Manisha Jhamb$6,862,629
- Yael Schenker$8,873,667
- Nicole N Scheff$4,386,699
- Brian M Miller$139,570
- Theresa Ann Koleck$1,006,766
Others in their field
Other Emerging Leaders on “Multiple Myeloma”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$6,010,647
- Gareth John Morgan · Tezcat Laboratories Llc$5,963,595
- Kimberly A. Bertrand · Boston University Medical Campus$5,843,599
- Paul M Barr · University Of Rochester$5,073,440
Research focus
Multiple MyelomaQuality Of LifeLifeMortalityProspectivePillFutureInterviewMalignant NeoplasmsMedication NonadherenceParticipantOralPatternPharmaceutical PreparationsAnti-CancerCancer TherapyAdherenceHematopoietic NeoplasmsAffectCostDesignMedication ComplianceClinically RelevantReporting
Grant awards (5)
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies$626,631
R01 · FY2025 · CA · contact PI
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies$656,560
R01 · FY2024 · CA · contact PI
Understanding Oral Anticancer Medication Adherence among Patients with Multiple Myeloma$120,529
K23 · FY2022 · NR · contact PI
Understanding Oral Anticancer Medication Adherence among Patients with Multiple Myeloma$123,796
K23 · FY2021 · NR · contact PI
Understanding Oral Anticancer Medication Adherence among Patients with Multiple Myeloma$123,799
K23 · FY2020 · NR · contact PI